Radiation Oncology/Therapy: Page 47

Accuray reports revenue gains for Q1
By AuntMinnie.com staff writers
Accuray reported gains in its preliminary financial results for the first quarter of the 2022 fiscal year, with the company citing an increase in gross orders as a growth driver.
October 21, 2021
2019 09 17 16 01 9179 Accuray Astro 2019
IBA launches Campus online proton therapy platform
By AuntMinnie.com staff writers
Proton therapy developer Ion Beam Applications (IBA) has launched Campus, an online proton therapy platform.
October 19, 2021
2019 09 21 00 44 1021 Iba Astro 2019
Varian highlights new offerings at ASTRO 2021
By AuntMinnie.com staff writers
Radiation oncology vendor Varian is emphasizing the benefits of its combination with Siemens Healthineers, as well as several new products, at the annual meeting of the American Society for Radiation Oncology (ASTRO), held October 24-27.
October 18, 2021
2020 01 30 01 49 9107 Varian Astro 2019 400
ITM secures supply deal with Clovis Oncology
By AuntMinnie.com staff writers
German radiopharmaceutical firm ITM Isotope Technologies Munich has signed an agreement to supply its EndolucinBeta no-carrier-added lutetium-177 radiopharmaceutical precursor to Clovis Oncology.
October 18, 2021
2021 09 14 23 49 7847 Business Handshake 400
Accuray to introduce Volo Ultra at ASTRO 2021
By AuntMinnie.com staff writers
Radiation oncology firm Accuray plans to feature its Volo Ultra planning upgrade at the annual meeting of the American Society for Radiation Oncology (ASTRO), which is being held October 24-27.
October 18, 2021
2019 09 17 16 01 9179 Accuray Astro 2019
ARTMS seeks nod from Health Canada for Ga-68 production
By AuntMinnie.com staff writers
ARTMS has submitted a drug master file to the Health Products and Food Branch of Health Canada for the production of gallium-68 (Ga-68).
October 13, 2021
2018 11 06 23 34 9504 Pet Scan Patient 400
Varian's Embozene microspheres receive 'breakthrough' designation
By AuntMinnie.com staff writers
Varian has received a breakthrough device designation from the U.S. Food and Drug Administration for its Embozene microspheres for genicular artery embolization for symptomatic knee osteoarthritis.
October 13, 2021
2020 01 30 01 49 9107 Varian Astro 2019 400
Sirtex touts 1st administration of yttrium-90 microspheres in China
By AuntMinnie.com staff writers
Radiation oncology firm Sirtex Medical is highlighting the successful first administration of its SIR-Spheres yttrium-90 resin microspheres in China.
October 10, 2021
2020 08 27 23 52 5591 China Flag Button 400
ASTRO highlights program at 2021 annual meeting
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) is highlighting research and clinical trial results it will feature at its annual meeting in Chicago from October 24 to 27.
October 10, 2021
2019 09 16 03 57 7061 Astro 2019 400
Consider the esophagus when it comes to breast cancer radiotherapy
By Amerigo Allegretto
Routinely avoiding the esophagus during radiation therapy for breast cancer may decrease the risk of esophageal cancer years later, according to research from Ireland published October 7 in Radiotherapy and Oncology.
October 10, 2021
2019 01 19 00 20 7950 Radiotherapy Breast Cancer 400
Alpha Tau gets FDA 'breakthrough' nod for brain tumor rad therapy
By AuntMinnie.com staff writers
Alpha Tau Medical recently received a breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Alpha DaRT treatment.
October 7, 2021
2018 07 24 00 33 7964 Brain 400
Nanobiotix highlights ASTRO research studies
By AuntMinnie.com staff writers
Nanobiotix will present results from clinical trials of its NBTXR3 radioenhancer at the 2021 American Society for Radiation Oncology (ASTRO) meeting, which will be held October 24-27 in Chicago.
October 6, 2021
2020 09 09 20 28 9240 Head Neck 400
Previous Page
Page 47 of 468
Next Page